Driving Impaired
17
1
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (17)
Validation of Alcohol Level Identification Using DRIVESC
Evaluation of an Interactive Mobile Phone-Based Brief Intervention to Reduce Substance-Impaired Driving
Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-withdrawal
Effectiveness of AV-stimulation in Immersive VR to Improve Visual Perception and Driving Performance
Using Advanced Driver Assistance Systems (ADAS) as an Intervention Strategy for Drivers With Parkinson's Disease
Fitness to Drive Among Stroke Patients
Cannabis Consumption and Driving Impairment Assessment on a Closed Course
Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests
Dose-response of Cannabis and Driving
Driving Simulation to Assess Non-Sedative Effects of Tolperisone
Driving Performance After Deep Sedation for Outpatient Endoscopy
Reducing Cell Phone Use While Driving Among High Risk UBI Auto Policy Holders
Effect of Postprandial Hyperinsulinaemic Hypoglycaemia on Driving Performance.
Driving Evaluation and Fitness for Persons With Cognitive Impairments
Neural Correlates of Driving and Cannabis
Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability
Smartphone-paired Breathalyzers and Loss- and Gain-framed Texts for Reducing Drinking and Driving